No. 46 Founders & operators
Chris Gibson
Cofounder and Chief Executive Officer, Recursion • United States
A biotech executive accelerating drug discovery using artificial intelligence.
Find on LinkedIn
The Signal
He actively writes about the convergence of tech and biology, demonstrating how automated workflows and machine learning can reduce the timeline of drug development.
Who Chris Gibson is
A biotech executive accelerating drug discovery using artificial intelligence.
He actively writes about the convergence of tech and biology, demonstrating how automated workflows and machine learning can reduce the timeline of drug development.
Loading the full dossier
At a glance
- Role
- Cofounder and Chief Executive Officer
- Organisation
- Recursion
- Platforms
- LinkedIn, X
- Based in
- United States, North America
Influence Score 87.6editorial estimate, see how it is built
Audience size across LinkedIn, X, YouTube, podcasts and newsletters.
How much the audience actually reacts, comments, shares and subscribes.
Clinical, research, operating or investing track record behind the commentary.
Publishing cadence and how reliably they show up with original work.
Whether decision makers, policy and capital actually move on what they say.
Scores are subjective editorial estimates compiled by our research desk from public profiles and published work. They are opinion, not measurement, and they are not a judgement of any person's character or ability.
Also in Founders & operators
This profile is compiled by our research desk from public sources and is published as editorial commentary. Want a correction, an update, or your profile removed? and see our corrections and removals policy.